Similar articles for PMID: 26839391

Year	Number of Results
2001	1
2002	1
2003	1
2004	2
2005	3
2006	4
2007	6
2008	2
2009	7
2010	4
2011	4
2012	7
2013	15
2014	8
2015	13
2016	5
2018	1
2020	1
2024	0

1

Femoropopliteal Artery Stent Thrombosis: Report From the Excellence in Peripheral Artery Disease Registry.

Banerjee S, Sarode K, Mohammad A, Gigliotti O, Baig MS, Tsai S, Shammas NW, Prasad A, Abu-Fadel M, Klein A, Armstrong EJ, Jeon-Slaughter H, Brilakis ES, Bhatt DL. Banerjee S, et al. Circ Cardiovasc Interv. 2016 Feb;9(2):e002730. doi: 10.1161/CIRCINTERVENTIONS.115.002730. Circ Cardiovasc Interv. 2016. PMID: 26839391 Free PMC article.

2

Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).

Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Ristl R, Schoder M. Lammer J, et al. J Am Coll Cardiol. 2013 Oct 8;62(15):1320-7. doi: 10.1016/j.jacc.2013.05.079. Epub 2013 Jul 10. J Am Coll Cardiol. 2013. PMID: 23831445 Free article. Clinical Trial.

3

Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis.

Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, Minar E. Sabeti S, et al. Radiology. 2004 Aug;232(2):516-21. doi: 10.1148/radiol.2322031345. Radiology. 2004. PMID: 15286322

4

Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).

Yan BP, Duffy SJ, Clark DJ, Lefkovits J, Warren R, Gurvitch R, Lew R, Sebastian M, Brennan A, Andrianopoulos N, Reid CM, Ajani AE; Melbourne Interventional Group. Yan BP, et al. Am J Cardiol. 2008 Jun 15;101(12):1716-22. doi: 10.1016/j.amjcard.2008.02.058. Epub 2008 Apr 9. Am J Cardiol. 2008. PMID: 18549846

5

SUMMIT registry: one-year outcomes after implantation of the EPIC self-expanding nitinol stent in the femoropopliteal segment.

Werner M, Piorkowski M, Thieme M, Nanning T, Beschorner U, Rastan A, Zeller T, Scheinert D. Werner M, et al. J Endovasc Ther. 2013 Dec;20(6):759-66. doi: 10.1583/13-4430R.1. J Endovasc Ther. 2013. PMID: 24325691

6

PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.

Lichtenberg M, Kolks O, Hailer B, Stahlhoff WF, Tiefenbacher C, Nolte-Ernsting C, Arjumand J, Wittenberg G. Lichtenberg M, et al. J Endovasc Ther. 2014 Jun;21(3):373-80. doi: 10.1583/13-4637R.1. J Endovasc Ther. 2014. PMID: 24915584

7

Femoropopliteal bypass vs percutaneous transluminal angioplasty and stenting in treatment of peripheral artery diseases of infrainquinal segment - short-term results.

Cvetanovski MV, Jovev S, Cvetanovska M, Blazevski B, Colanceski R, Andreevska T, Gramatnikovski N, Kartalov A. Cvetanovski MV, et al. Prilozi. 2009 Jul;30(1):105-18. Prilozi. 2009. PMID: 19736534

8

Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial.

Garcia L, Jaff MR, Metzger C, Sedillo G, Pershad A, Zidar F, Patlola R, Wilkins RG, Espinoza A, Iskander A, Khammar GS, Khatib Y, Beasley R, Makam S, Kovach R, Kamat S, Leon LR Jr, Eaves WB, Popma JJ, Mauri L, Donohoe D, Base CC, Rosenfield K; SUPERB Trial Investigators. Garcia L, et al. Circ Cardiovasc Interv. 2015 May;8(5):e000937. doi: 10.1161/CIRCINTERVENTIONS.113.000937. Circ Cardiovasc Interv. 2015. PMID: 25969545 Clinical Trial.

9

Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.

Zeller T, Peeters P, Bosiers M, Lammer J, Brechtel K, Scheinert D, Rastan A, Noory E, Beschorner U. Zeller T, et al. J Endovasc Ther. 2014 Dec;21(6):765-74. doi: 10.1583/14-4790R.1. J Endovasc Ther. 2014. PMID: 25453876 Clinical Trial.

10

Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.

Ullery BW, Tran K, Itoga N, Casey K, Dalman RL, Lee JT. Ullery BW, et al. J Vasc Surg. 2015 Jun;61(6):1479-88. doi: 10.1016/j.jvs.2014.12.062. Epub 2015 Feb 19. J Vasc Surg. 2015. PMID: 25704407 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year